Efficacy and safety of bispecific antibodies vs. immune checkpoint blockade combination therapy in cancer: a real-world comparison

Abstract Emerging tumor immunotherapy methods encompass bispecific antibodies (BSABs), immune checkpoint inhibitors (ICIs), and adoptive cell immunotherapy. BSABs belong to the antibody family that can specifically recognize two different antigens or epitopes on the same antigen. These antibodies de...

Full beskrivning

Bibliografiska uppgifter

Huvudupphov:	Linyan Cheng, Lujun Chen, Yuan Shi, Weiying Gu, Weidong Ding, Xiao Zheng, Yan Liu, Jingting Jiang, Zhuojun Zheng
Materialtyp:	Artigo
Språk:	Inglês
Utgiven:	BMC 2024-04-01
Serie:	Molecular Cancer
Ämnen:	Bispecific antibodies Immune checkpoint inhibitors Cancer Efficacy Safety
Länkar:	https://doi.org/10.1186/s12943-024-01956-6
Taggar:	Lägg till en tagg Inga taggar, Lägg till första taggen!